Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair–Deficient Colon Cancer
Chalabi, Myriam, Verschoor, Yara L., Tan, Pedro Batista, Balduzzi, Sara, Van Lent, Anja U., Grootscholten, Cecile, Dokter, Simone, Büller, Nikè V., Grotenhuis, Brechtje A., Kuhlmann, Koert, Burger, Jacobus W., Huibregtse, Inge L., Aukema, Tjeerd S., Hendriks, Eduard R., Oosterling, Steven J., Snaebjornsson, Petur, Voest, Emile E., Wessels, Lodewyk F., Beets-Tan, Regina G., Van Leerdam, Monique E., Schumacher, Ton N., van den Berg, José G., Beets, Geerard L., Haanen, John B.
Published in The New England journal of medicine (06.06.2024)
Published in The New England journal of medicine (06.06.2024)
Get full text
Journal Article
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Verschoor, Yara L., van de Haar, Joris, van den Berg, José G., van Sandick, Johanna W., Kodach, Liudmila L., van Dieren, Jolanda M., Balduzzi, Sara, Grootscholten, Cecile, IJsselsteijn, Marieke E., Veenhof, Alexander A. F. A., Hartemink, Koen J., Vollebergh, Marieke A., Jurdi, Adham, Sharma, Shruti, Spickard, Erik, Owers, Emilia C., Bartels-Rutten, Annemarieke, den Hartog, Peggy, de Miranda, Noel F. C. C., van Leerdam, Monique E., Haanen, John B. A. G., Schumacher, Ton N., Voest, Emile E., Chalabi, Myriam
Published in Nature medicine (01.02.2024)
Published in Nature medicine (01.02.2024)
Get full text
Journal Article
Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Verschoor, Yara L., van de Haar, Joris, van den Berg, José G., van Sandick, Johanna W., Kodach, Liudmila L., van Dieren, Jolanda M., Balduzzi, Sara, Grootscholten, Cecile, IJsselsteijn, Marieke E., Veenhof, Alexander A. F. A., Hartemink, Koen J., Vollebergh, Marieke A., Jurdi, Adham, Sharma, Shruti, Spickard, Erik, Owers, Emilia C., Bartels-Rutten, Annemarieke, den Hartog, Peggy, de Miranda, Noel F. C. C., van Leerdam, Monique E., Haanen, John B. A. G., Schumacher, Ton N., Voest, Emile E., Chalabi, Myriam
Published in Nature medicine (01.05.2024)
Published in Nature medicine (01.05.2024)
Get full text
Journal Article
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial
de Gooyer, Peter G. M., Verschoor, Yara L., van den Dungen, Lauren D. W., Balduzzi, Sara, Marsman, Hendrik A., Geukes Foppen, Marnix H., Grootscholten, Cecile, Dokter, Simone, den Hartog, Anne G., Verbeek, Wieke H. M., Woensdregt, Karlijn, van den Broek, Joris J., Oosterling, Steven J., Schumacher, Ton N., Kuhlmann, Koert F. D., Beets-Tan, Regina G. H., Haanen, John B. A. G., van Leerdam, Monique E., van den Berg, Jose G., Chalabi, Myriam
Published in Nature medicine (01.11.2024)
Published in Nature medicine (01.11.2024)
Get full text
Journal Article
Radiotherapy, atezolizumab, and bevacizumab in rectal cancers with the aim of organ preservation: The TARZAN study
Verschoor, Yara L., Lambregts, Doenja M. J., van den Berg, José, Grotenhuis, Brechtje A., Aalbers, Arend, Van Triest, Baukelien, Beets-Tan, Regina G.H., van de Belt, Marieke, Dokter, Simone, Balduzzi, Sara, Voest, Emile E., Haanen, John B. A. G., van Leerdam, Monique E., Beets, Geerard, Chalabi, Myriam
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Neoadjuvant atezolizumab plus docetaxel/oxaliplatin/capecitabine in non-metastatic gastric and gastroesophageal junction adenocarcinoma: The PANDA trial
Verschoor, Yara L., Kodach, Liudmila, van den Berg, José, van Sandick, Johanna W., van Dieren, Jolanda, Balduzzi, Sara, Grootscholten, Cecile, Veenhof, Xander, Hartemink, Koen, Vollebergh, Marieke A., Owers, E.C., Bartels-Rutten, Annemarieke, den Hartog, Peggy, van Leerdam, Monique E, Schumacher, Ton, Voest, Emile E., Haanen, John B. A. G., Chalabi, Myriam
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Neoadjuvant nivolumab, ipilimumab, and celecoxib in MMR-proficient and MMR-deficient colon cancers: Final clinical analysis of the NICHE study
Verschoor, Yara L., van den Berg, José, Beets, Geerard, Sikorska, Karolina, Aalbers, Arend, van Lent, Anja, Grootscholten, Cecile, Huibregtse, Inge, Marsman, Hendrik, Oosterling, Steven, van de Belt, Marieke, Kok, Marleen, Schumacher, Ton, van Leerdam, Monique E, Haanen, John B. A. G., Voest, Emile E., Chalabi, Myriam
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article